# XELJANZ

NDC: 0069-1029
Generic name: tofacitinib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20210208

FDA application: NDA213082

## Active ingredients

- TOFACITINIB CITRATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-1029"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-1029
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831